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In chick embryo, certain paramyxoviruses mainly target the chorioallanlois and the allanloamnion and show no exrensivc further spreading in the 
other organs. This has been explained by the possible presence of an endoprotease activa@t the viral fusion glycoprolcin precursor in the allanloic 
and the amniotic Iluid, and its absence in other places or organs. We previously isolated such an endoprotease from the allunloic fluid und 
demonstrated its identity with the clotting factor Xa. Exactly the same endoprotcase by all the criteria including the N-~crminal amino acid sequence 
was now isolated from the amniotic fluid. Thus, the factor Xa seems LO bc a major host determinant of the viral tropism in chick embryo. 
Virus activating protease; Factor X: Viral tropism: Chick amniotic fluid 
I. INTRODUCTION 
Enveloped animal viruses usually possess a surface 
glycoprotein which mediates fusion between the viral 
envelope and host cell membrane. An essential step in 
the biosynthesis of the fusion glycoprotcin is the post- 
translational endoproteolytic cleavage of the inactive 
precursor glycoprotcin by host cell proteases. For ex- 
ample, the fusion (F) glycoprotein of Sendai virus and 
Newcastle disease virus (NDV) in paramyxoviridae is 
synthesized in a form of precursor FO protein, and the 
specific endoproteolysis of FO into two subunits, the 
N-terminal F2 and the C-terminal Fl, is essential for the 
expression of the viral fusion activity and infectivity 
[l-3]. The hydrophobic stretch of some 25 amino acids 
generated at the Fl N terminus by cleavage is thought 
to be the direct mediator of fusion activity [4]. Depend- 
ing upon whether the cleavage site consists of a single 
arginine or di- or oligo-basic residues, the viral FO pro- 
tein is activated by a particular protease produced by 
a few particular tissues or by a ubiquitous protease 
present in a wide variety of tissues [S-7]. Since the spe- 
cific receptors for these viruses are widespread sialic 
acid-containing molecules, the different protease de- 
pendency specified by those cleavage motifs in the FO 
precursor could be a direct determinant of the viral 
tropism. In cells cultured in vitro, viruses of the former 
type require exogenously added trypsin or a trypsin-like 
enzyme to undergo multiple rounds of replication, while 
the latter shows no such requirement. 
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The protease-dependency of viral tropism was strik- 
ingly illustrated in studies of virulent and avirulent 
strains of NDV in chick embryo (CE), where the vi- 
rulent strains with an oligo-basic cleavage motif spread 
throughout the embryo, while the infection of avirulent 
strains with a single arginine motif is limited to certain 
tissues such as chorioallantois [S]. This simple model 
host organism further provided another striking exam- 
ple by the use of Sendai virus and its protease-activation 
mutants [9,10]. The FO of wild type has a single arginine 
motif and like avirulent NDV, replicates well in the 
chorioallantois but does not spread extensively in other 
organs. The mutants, which were altered to require chy- 
motrypsin or elastase for FO activation but could no 
longer be activated by trypsin, now failed to replicate 
even in the CA. These data suggested that a trypsinalike 
protease was responsible for Sendai virus activation 
in the chorioallantois of CE. Furthermore, one of the 
protease-activation mutants was found to have lost the 
capacity to produce pneumonea in mice, suggesGng the 
involvement of similar proteases in viral spread and 
pathogenesis in the natural host [lo]. However, no fur- 
ther extensive characterization of the proteases has been 
done. This is a major obstacle for full understanding of 
protease-dependent viral tropism. Exemplifng such 
proteases for the first time, we recently isolated a virus- 
activating prolease (VAP) from CE. This enzyme puri- 
fied from the allantoic fluid (ALF) filling the CA, speci- 
fically cleaved the FO of Sendai virus and avirulent 
NDV, and was demonstrated to be identical with the 
clotting factor Xa (FXa) [ 11 ,121. The amnion sac in CE 
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is another major site targeted by these viruses. Is the 
same protease involved in virus-activation at this site? 
If different, how diverse can the enzymes be, which 
participate in activation in different places of a single 
host organism’? To solve these questions, we have here 
attempted to isolate the responsible amniotic protease 
and demonstrated that the isolated enzyme is also the 
FXa, expanding the significance of FXa as a host deter- 
minant of viral tropism in CE. 
2. MATERIALS AND METHODS 
Sendai virus. grown in LLCMK? cells and containing cxclusivcly 
the inactive FO precursor. was used as the substrate ol’VAP assay. The 
VAP assay consists of clcavagc ol’ the substrate virion FO protein 
Ibllowed by measurcmcnt ~Thcmolysis, an event resulting t?om fusion 
bctwccn the viral envelope and the erythrocytu mcmbranc. The rcac- 
tion mixture consisting or IOOyl of the virus (-3,200 hcmagglutinat- 
iny units) in 20 mM Tris-HCI, pH 7.4, I50 mM NaCl (TN), and 100 
~1 of serial two-fold dilutions (with TN) or the rractions to bc tesicd. 
wcrc incubotcd at 37°C for I h in the presence or2.5 mM CaC12. AtIer 
adding 50 ,ul ol’O.0 I% soybean trypsin inhibitor and IOOyl of50 mM 
EDTA. the reaction mixture received I ml or?% chicken crythrocytcs 
in phoaphatc-burered sulinc and was rurthcr incubated at 37°C ror 
I h. Alier low-speed centrirugation, the hemoglobin r&used into the 
supernatant was measured by absorbance at 540 nm (OD,,,) [I I]. The 
VAP activities in Table I and the ligurcs wcrc expressed as a relative 
hcmolytic activity within a range whcrc the amount of VAP and 
hcmolysis were proportional. 
As in the CHSC ol*VAP-isolation rrom the ALF. we used hcrc a Iluid 
lilling the target organ. namely the amniotic fluid (AM F). All the steps 
were carried out at 4°C. The AMF (I.7 liters) was mixed with 170 ml 
of 3.8% sodium citrate. and was then subjcctcd to precipitation by 
adding 170 ml of I M DaCI, and ccntril’ugation at IWO0 x g Ibr IO 
min. The barium chratc precipitates were washed 3 times with 100 ml 
ordistilled warcr, solubilizcd by adding 60 ml of0.5 M EDTA pH 8.0. 
and dialyzed against 5 liters or50 mM imidazolc-HCI pH 6.0. (buflix 
IB). AIIcr removing insoluble subsianccs by centrirugation ut 10,000 
x g ror IO min. the dialysatc was londcd onto I HeparinGpharosc 
CL-GB column (3 x 5 cm) (Pharmacia, Stockholm) pre-cquilibralcd 
with ID at a flow rate of0.5 ml/min, and stcpwise-elutcd with 0.1.0.6. 
and I .O M NsCl in the same bulTer. The 0.6 M NaCI rruction, coniain- 
ing the bulk of VAP. was dialyacd overnight against TN and cen- 
triruged at 10.000 x g lbr 10 min. and was loaded onto a I ml Mono 
Q column (pru-equilibrated with TN) at a flow rate of 0.5 mhin. 
After a IO ml wash with 0.2 M NaCl in 20 mM Tris-HCI. pH 7.4, the 
elution was performed with n 25 ml linear gradient oT0.Z0.7 M NaCl 
in the same buffer and tbc activity was recovered in - 0.4 M fractions. 
The YAP was Anally purified into homogcncity by Scphacryl S-200 
HR (I.5 x 77 cm) gel filtration. 
N.tcrminal amino acid scqucncing of proteins blotted onto polyvi- 
nilidcnc difluoridc membranes (Milliporc. Bedford. MA) was per- 
l’ormed as previously dcscribcd [I I ] on an Applied Biosystems Model 
470 A protein sequencer at the Ccntcr for Grnc Research, Nagoya 
University. Sodium dodccyl sull’atc polyacryl amide gel clcctrophorc. 
sis (SDS-PAGE) with 3.5% stacking and IO or 12.5% sepamting gels 
was pcrrormcd according to Lacmmli [ 131. Gels wcrc Coomassie bluc- 
or silver-stained [I I]. Protein concentration +~a measured by the dyc- 
binding method [ 141. Propagation in LLCMKZ cells of Scndai virus, 
NDV (strain Ulster) and Inllucnza A virus (strain PR/8/34) and their 
purilication were as previously described [3.1 I]. 
3. RESULTS 
Table I summarizes the purification steps of VAP 
from the AMF (VAPam). The starting material was 
about 1.7 liters of AMF from uninfected, Il-day-old 
embryos (Table I, step I; Fig. IA, lane I). The AMF 
was harvested without any appreciable contamination 
with ALF [IS]. FXa contains y-carboxyglutamic acid 
(Gla) residues characteristic of vitamin K-dependent 
proteins. Here. we took advantage of the features that 
such proteins are selectively adsorbed onto barium 
citrate salts [ 16,171, which had not been taken into con- 
sideration for the previous isolation of VAP from the 
ALF (VAPal). The barium citrate precipitation already 
resulted in a dramatic enrichment of VAP activity 
(Table I, step 2). No VAP activity was detected in the 
supernatant. In the subsequent step of Heparin- 
Sepharosc CL-6B column chromatography, the bulk of 
VAP was eluted into the 0.6 M NaCl fraction (Table I. 
step 3). This fraction still contained a number of 
proteins besides VAP (Fig. IA, lane 3). The material 
was then subjected to Mono Q FPLC, which yielded a 
sharp peak of activity at the fractions 14 and 15 around 
0.4 M NaCl (Fig. 1 B) with a striking increase in specific 
activity (Table I. step 4). Final purification was ac- 
complished by Sephacryl S-200 HR gel filtration (Fig. 
2A) with about SOO-fold increase in the specific activity 
(Table I, step 5). After concentration of a pool of frac- 
tions 13-l 7 in Fig. 2A by lyophilization, we carried out 
SDS-PAGE and found that the VAPam was a 55 kDa 
hcterodimer consisting of a 33 kDa and a 23 kDa sub- 
unit (Fig. 2B). Thus, both the molecular mass and the 
subunit composition of the VAPam were identical to 
those of VAPal [l 11. 
Table I 
Purification of VAP from AMF 
Step Volullle Total protein Yield Rclativc specific activity 
(ml) (m6) (%) 
.^ 
I. AMF 1700 I47 (100) (I) 
2. Baricm citrate precipilate IO0 3.20 72 33 
3. Heparin~Sepharose CL-GB 55 I.90 52 40 
4. Mono Q FPLC 2 0.162 20 I82 
5. Sephacryl S-200 HR IO 0.014 5 525 
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Fig. 1, SDS-PAGE of the VAP-containing materials in each of the purification steps in Table I (A) and the Mono Q chromstography of the materials 
obtttined ttt step 3 in Table I (EJ). The numbers on the top of the gel lanes in A correspond to those of Ihe purification steps in Table 1. lnsert in 
B, SDS-PAGE of the fractions 13-16. 4, positions of the heavy and tbc light chain of VAP. &Is were all silver-stuined. 
3.2. Proteolytic uctisution by VAParn of the viral fusion 
glycoprotein precursors 
The isolated VAPam could cleave not only Sendai 
virus FO but also the FO of NDV avirulent strain 
(Ulster) with an enhancement of viral hemolysis (Fig. 
3). The cleavage of NDV hemagglutinin-neuraminidase 
precursor (HNO) into the biologically active hemagglu- 
tinin-neuraminidase (HN), was also induced (Fig. 3). 
Influenza virus hemagglutinin (HA) also requires 
proteolytic cleavage for expressing membrane fusion 
activity. The VAPam induced this activation too, as 
exemplified by IX/S/34 strain of H 1 subtype whose HA 
has a single arginine cleavage-motif and is processed 
into HA1 and HA2 by the enzyme (Fig. 3). Thus, the 
VAPam was found to possess a substrate specificity 
very similar to that of VAPal [l 11. The requirement of 
97.4- - 97.4 
- 66,2 
ba 55 -42.7 
31.0- 33-g -31.0 
FRACTION NUMBER 
Fig, 2. Chromatography by Sephacryl S-200 HR of the VAP-conraining material recovered from the fractions I4 and I5 in Fig. 111 of the Mono 
Q chromatography (A) and SDS-PAGE under nonreducing (NR) and reducing (R) conditions of the VAP from the pool of fractions (fr. 13-17) 
in A (B). Yo, void volume. 
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I YP Activity [OD5493 
Fig. 3. SDS-PAGE under reducing conditions of Scndni virus. NDV, 
and influenza virus A (FluA) proteins that wcrc treated (+) with 0.5 
/.@rnl of puriftcd VAPam for GO min at 37°C. or left untreated (-). 
Gels were stained with Coomassic blue. and migration was from left 
to right. I-lemolytic activity of viruses treated or untreated with 
VAPam is shown on the right ofcach gel, l-lrmolysis by the influenza 
virus was measured at pll 5.0 us described previously [I I]. 
Ca”’ (1.2 mM or more) and the pH range (7.2-8.0) for 
the optimal action of VAPam were also very similar to 
those found for VAPai [l I]. 
3.3. hr-tetwtittal mtitto acid seqrretwit~g of VAPfft?z 
The identity between the VAPam and VAPai was 
finally established by amino acid sequencing of the N 
termini of both the 33 kDa and the 23 kDa chain. As 
shown in Fig. 4. the sequences were exactly the same 
amongst he VAPam, VAPal, and the chicken FXa. We 
should note that Glu residues in the 23 kDa chain of 
these 3 molecules could only be identified by heating the 
blotting membranes at 100°C in dryness prior to se- 
quencing, strongly suggesting that these residues are 
indeed y-carboxylated to serve as the Ca” binding sites 
LIGHT CHAIN 
HEAVY CHAIN 
1 10 
VAPam IVGGDEXRPGEXPWQ*VL~~E 
VAPal -__-__-____-_x_______ 
CFX _______^_____ _____ _ 
HFX ____Q_CKD__C_X__‘__X_ 
BFX ----RDCAE-_C-_--L-V__ 
Fig. 4. Alignment of N-terminal amino acid sequences of the 23 kDa 
light and thu 33 kDa heavy chain of VAi%m with those of YApal, 
chicken factor X (CFX), human factor X (I-iFX), and bovine factor 
X (BFX). Single letter code is used. The shadowed E residues wcrc 
suggested to be ~carboxylaled [I I]. X. unidcndficd. 
[l 1,181. The molecular mass of 55 kDa defined here is 
in good agreement with that of a Sendai virus-activating 
protease also partially purified from the AMF of CE by 
Appleyard and Davis [19]. 
4. DISCUSSION 
The results presented here unequivocally show that 
the virus-activating capacity of AMF is attributable to 
the FXa present in the fluid, as in the case of the al- 
lantoic fluid. In the beginning of this work, however, WC 
did not always expect this conclusion, because there 
could be a number of different endoproteases in a living 
organism, or perhaps even in a living cell, which are 
potentially able to cleave the carboxyl side of an ar- 
ginine. We previously found the presence of the en- 
zymaticaily inactive precursor to VAP (pVAP) in the 
ALF [I I]. The molar ratio of pVAP to VAP was about 
4-to- 1. The pVAP is equivalent to the inactive rymogen, 
FX, and was converted to VAP by limited proteolysis 
with Russell’s viper venom in the identical manner 
found for conversion of FX to FXa [ll]. In the AMF, 
however, only the VAP but no detectable pVAP has 
been found, indicating that the precursor is completely 
processed there. Thus the metabolism of pVAP appears 
to be somewhat different in these two fluids, although 
the native proteasc(s) for conversion of pVAP to VAP 
remains to be identified. The concentrations of VAP in 
the AMF and the ALF were calculated to be approxi- 
mately 0.16 ,@mi and 0.03 &ml, respectively. This 
difference may explain that Sendai virus activating ca- 
pacity of the AMF was about 10 times higher than that 
of the ALF [19]. 
In order to obtain more direct proof for the in vivo 
role of FXa in virus activation and spreading, we need 
a number of studies including the protease gene expres- 
sion and the processing of the gene products from the 
precursor to the active form at a tissue level and their 
correlation with the viral tissue specificity or tropism. 
These studies have recently demonstrated that although 
FX is generally synthesized in the liver, many other 
tissues in the CE, including the chorioallantois and the 
allantoamnion, produce the FX that is the biologically 
active FXa, however, present only in the AMF and the 
ALF, and that the paramyxoviruses replicate only in 
those tissues in direct contact with these fluids [20]. 
These results and those presented here and obtained 
previous!y [ 1 I ,I 21 seem to complement one another very 
well, and suggest strongly that the FXa is of prime 
importance as a host determinant of viral tropism in 
CE. Undoubtedly, the FXa is not present in CE for the 
sole purpose of activating the viruses. Its normal ccl- 
lular functions are not known and deserve investigation 
in view of the facts that prothrombin-like proteases 
appear to play roles in other bioiogicai processes than 
blood clotting, including cell differentiation and em- 
bryogenesis [21-23). 
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